RTRoberta Torres

Roberta Torres

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roberta Torres has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Metrics Reflecting Cumulative Exposure to Nocturnal Hypoxia Demonstrate Promising Performance in Distinguishing between Moderate and Severe Obstructive Sleep Apnea

    by Shirley Nogueira de Souza, Jose Carlos Nóbrega Júnior, Roberta Torres, Thayse Neves Santos Silva, Gilvandro da Rocha Pessoa, Liliane Patrícia de Souza Mendes, Daniella Brandão, Shirley Campos, Armèle Dornelas de Andrade

    The apnea-hypopnea index is traditionally used to classify the severity of obstructive sleep apnea; however, it does not fully capture the cumulative physiological impact of nocturnal hypoxia. Metrics that quantify integrated hypoxic exposure may provide a more accurate characterization of disease severity. The current study compared the independent association and discriminative performance of hypoxic burden, cumulative time with peripheral oxygen saturation below 90%, and oxygen desaturation frequency in distinguishing between moderate and severe obstructive sleep apnea. In total, 30 patients with moderate or severe disease were evaluated using actigraphy combined with continuous nocturnal oximetry. Separate logistic regression models adjusted for body mass index were developed. Hypoxic burden and cumulative time with peripheral oxygen saturation below 90% remained independently associated with severe disease, with odds ratios of 1.35 (95%CI: 1.05–1.75; p = 0.021) and 2.46 (95%CI: 1.03–5.90; p = 0.043) respectively, whereas desaturation frequency was not significant after adjustment (odds ratio: 1.90; 95%CI: 0.97–3.73; p = 0.061). The model including cumulative time with peripheral oxygen saturation below 90% yielded an area under the curve of 0.86 (95%CI: 0.728–0.996), while the models including hypoxic burden and desaturation frequency yielded values regarding the area under the receiver operating characteristic (ROC) curve of 0.84 (95%CI: 0.698–0.989) and 0.78 (95%CI: 0.618–0.954) respectively. These findings suggest good discriminative performance of metrics reflecting cumulative nocturnal hypoxic exposure; however, formal comparisons between the ROC curves were not performed. Metrics reflecting cumulative exposure to nocturnal hypoxia demonstrated promising performance in distinguishing between moderate and severe disease, and they may contribute to risk stratification in obstructive sleep apnea.

  • Open Access

    Inspiratory muscle fatigue and pulmonary deposition/perfusion imaging predict sleep dysfunction in long COVID: Evidence from MTC scintigraphy and FIT performance metrics

    by Jose Carlos Nóbrega Júnior, Simone Soares Brandão, Magno F. Formiga, Daiara Xavier, Roberta Torres, Shirley Nogueira de Souza, James B. Fink, Arzu Ari, Cyda Reinaux, Daniella Brandão, et al.

  • Open Access

    Respiratory Rehabilitation After COVID-19: Efficacy of Inspiratory Muscle Training on Lung Function, Quality of Life and Sleep Quality: A Randomized Clinical Trial

    by Jose Carlos Nóbrega Júnior, Daniella Brandão, Daiara Xavier, Roberta Torres, Simone Soares Brandão, Magno Formiga, James B. Fink, Arzu Ari, Shirley Campos, Armèle Dornelas de Andrade

    Background and Purpose: Post-COVID-19 syndrome significantly impacts respiratory function and quality of life. Inspiratory muscle training (IMT) has been proposed as a potential intervention to improve respiratory muscle strength and overall recovery. This study aimed to evaluate the effects of IMT on respiratory muscle performance, lung function, functional capacity, sleep quality, and quality of life in individuals with post-COVID-19 syndrome. Methods: Nineteen individuals with post-COVID-19 syndrome were randomized into an IMT group (N = 10) or a sham group (N = 9). The IMT group performed eight weeks of training at 50% of maximal inspiratory pressure (MIP), while the sham group used a non-load device. Outcomes included MIP (cm H2O), functional capacity (6MWT), lung function (spirometry), sleep quality (PSQI), and quality of life (SF-36). Results: The IMT group showed significant improvements in MIP (125.50 ± 22.50 vs. 93.67 ± 20.87 cm H2O; p = 0.036; Cohen’s d = 0.50), PSQI (4.40 ± 2.50 vs. 9.00 ± 2.80; p = 0.011; Cohen’s d = 0.60), and SF-36 (p = 0.030). The IMT group also increased 6MWT distance by 58.36 ± 25.10 m. Conclusions: IMT significantly improved respiratory muscle strength, sleep quality, and quality of life in post-COVID-19 syndrome. These findings suggest that IMT may be an effective intervention, warranting further studies to confirm long-term benefits.


  • Open Access

    Long COVID: Ventilation and Perfusion Are Reduced in Symptomatic Individuals Compared to Asymptomatic Patients—A V/Q Scintigraphy Study

    by Jose Carlos Nóbrega Júnior, Simone Soares Brandão, James B. Fink, Daiara Xavier, Roberta Torres, Arzu Ari, Caio Morais, Shirley Campos, Daniella Brandão, Armèle Dornelas de Andrade

    Pulmonary dysfunction is a common sequel of COVID‐19, with long‐term effects on lung function even after recovery. Traditional imaging methods like computed tomography (CT) and X‐ray often fail to detect subtle functional impairments. In contrast, ventilation and perfusion scintigraphy (V/Q scintigraphy) provide a sensitive assessment of regional ventilatory and perfusion abnormalities, revealing functional changes missed by anatomical imaging. To compare the regional pulmonary distribution of radiopharmaceuticals in symptomatic and asymptomatic post‐COVID‐19 individuals. A cross‐sectional study was conducted with 33 post‐COVID‐19 individuals, categorized into asymptomatic (n = 10) and symptomatic groups (n = 23), classified according to symptom severity. Ventilation and perfusion scintigraphy were performed using technetium‐99m radiopharmaceuticals (99mTc‐DTPA for ventilation and 99mTc‐MAA for perfusion). Pulmonary radiopharmaceutical activity was quantified using Regions of Interest (ROIs) in central and peripheral zones and upper, middle, and lower regions. Symptomatic patients showed significantly lower radiopharmaceutical activity in all pulmonary regions compared to asymptomatic participants (p < 0.05). Perfusion analysis revealed significantly higher total lung radiopharmaceutical counts in asymptomatic individuals (Median [IQR]: 1046.94 [447.41] Kct) compared to symptomatic individuals (765.66 [269.94] Kct, p = 0.002). No significant differences were found in the left lung regions. The total pulmonary count during the ventilation phase progressively decreases as disease severity increases. The comparison between the extremes (asymptomatic vs. severe) reveals a nearly 50% reduction in pulmonary counts. Significant differences in pulmonary radiopharmaceutical activity were observed between groups, with reduced ventilatory and perfusion functionality in symptomatic patients. These findings underscore the importance of advanced techniques for monitoring and individualized rehabilitation of post‐COVID‐19 patients.


  • Impact of COVID-19 severity on sleep parameters, exercise tolerance, respiratory muscle strength, pulmonary function, and quality of life: a cross-sectional study

    by Jose Carlos Nóbrega Júnior, Anna Myrna Jaguaribe de Lima, Daiara Xavier, Roberta Torres, Magno Formiga, Daniella Brandão, Shirley Campos, Armèle Dornelas de Andrade

    To investigate the impact of post-COVID-19 infection severity on lung function, exercise tolerance, sleep parameters, and quality of life. A cross-sectional study with 30 individuals (age 44.27±14.88 years; 70% women) affected by COVID-19 (23.37±3.49 months after acute infection) was divided into 3 groups: control, mild, and moderate/severe. Evaluations included: submaximal aerobic capacity, respiratory muscle strength, lung function, sleep parameters and quality of life. The moderate/severe group showed lower results for the predicted percentage of FEV1/FVC (p=0.004) and significant differences in sustained maximum inspiratory pressure (SMIP) and fatigue index (FIT) (p<0.05). They also showed reduced exercise tolerance with shorter walking distances (p<0.001), poorer sleep quality, excessive daytime sleepiness, lower sleep efficiency (p=0.032), longer sleep latency (p<0.001), and more awakenings (p=0.006). Quality of life was reduced in three of the eight domains assessed. Individuals with moderate/severe COVID-19 exhibited impaired pulmonary function, reduced sleep efficiency, more awakenings, and lower quality of life compared to those with asymptomatic or mild cases.